CalciMedica is trading at $1.47, up 5.0%, with no clear company-specific catalyst identified for the November 3 move. - The XBI was reported up 2.13% during the regular session, offering a possible sector backdrop but not establishing the cause of CalciMedica’s move. - CalciMedica announced participation in a healthcare conference scheduled for November 10.